Physician

Dana Williams Chopra, M.D.

According to 2025 Medicare claims, Dana Chopra, M.D. (NPI: 1194189183) practices geriatric medicine in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is ONE MEDICAL, P.C. (NPI: 1932669462; TIN: 371920609) and primary practice location at 28226-3765. Chopra is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and Iora Health NE DCE, LLC (DBA Iora Health Network) (ACO ID: D0004), participating under both the MSSP and REACH models.

Chopra's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 159 traditional Medicare patients, billed 576 HCPCS/CPT codes, and received $33,950 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,496 prescription claims across 392 beneficiaries totaling $254,893 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 1 records totaling $154. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,624 to $254,893. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	51	86	$6,486
2021	102	362	$31,270
2022	171	324	$25,539
2023	176	440	$35,372
2024	159	576	$33,950

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	25	96	$5,624
2018	39	297	$21,996
2019	44	369	$41,773
2020	110	567	$60,130
2021	158	2,024	$207,827
2022	292	1,959	$206,954
2023	365	2,875	$250,651
2024	392	3,496	$254,893

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	15	15	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	126	250	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	64	89	$61
87426	Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus	13	13	$35
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	81	123	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	34	1,600	$30,396
Januvia	Sitagliptin Phosphate	23	1,415	$25,365
Jardiance	Empagliflozin	13	930	$18,212
Tradjenta	Linagliptin	14	1,020	$16,584
Myrbetriq	Mirabegron	21	912	$13,871

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$154	Davol Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dana Williams Chopra, M.D.?

Tedicare shows public-source Medicare data for Dana Williams Chopra, M.D. (NPI 1194189183), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dana Williams Chopra, M.D. have ACO affiliation data?

Dana Williams Chopra, M.D. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and Iora Health NE DCE, LLC (DBA Iora Health Network) (REACH, ACO ID D0004).

What billing organization is linked to Dana Williams Chopra, M.D.?

Dana Williams Chopra, M.D. is linked to ONE MEDICAL, P.C. (billing NPI 1932669462) in the available physician profile data.

Does Dana Williams Chopra, M.D. have Open Payments data?

Dana Williams Chopra, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.